Argen-X (LSE:0QW0) — Market Cap & Net Worth
Market Cap & Net Worth: Argen-X (0QW0)
Argen-X (LSE:0QW0) has a market capitalization of $13.37 Billion (€11.44 Billion) as of August 2, 2026. Listed on the LSE stock exchange, this UK-based company holds position #1772 globally and #6 in its home market, demonstrating a -5.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Argen-X's stock price €748.00 by its total outstanding shares 32450800 (32.45 Million). See Argen-X capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Argen-X Market Cap History: 2015 to 2026
Argen-X's market capitalization history from 2015 to 2026. Data shows growth from $352.83 Million to $28.38 Billion (50.84% CAGR).
Argen-X Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Argen-X's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.44x
Argen-X's market cap is 10.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
28.24x
Argen-X's market cap is 28.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $352.83 Million | $7.49 Million | -$16.74 Million | 47.08x | N/A |
| 2016 | $504.58 Million | $15.47 Million | -$22.48 Million | 32.61x | N/A |
| 2017 | $1.86 Billion | $43.69 Million | -$33.68 Million | 42.57x | N/A |
| 2018 | $3.23 Billion | $24.57 Million | -$76.23 Million | 131.38x | N/A |
| 2019 | $5.47 Billion | $78.46 Million | -$181.21 Million | 69.68x | N/A |
| 2020 | $9.16 Billion | $41.24 Million | -$608.46 Million | 222.06x | N/A |
| 2021 | $11.96 Billion | $497.28 Million | -$408.26 Million | 24.06x | N/A |
| 2022 | $13.32 Billion | $410.75 Million | -$709.59 Million | 32.43x | N/A |
| 2023 | $13.10 Billion | $1.23 Billion | -$295.05 Million | 10.68x | N/A |
| 2024 | $22.71 Billion | $2.17 Billion | $804.13 Million | 10.44x | 28.24x |
Competitor Companies of 0QW0 by Market Capitalization
Companies near Argen-X in the global market cap rankings as of August 2, 2026.
Key companies related to Argen-X by market ranking:
- Azrieli Group Ltd (TA:AZRG): Ranked #1763 globally with a market cap of $13.46 Billion USD ( ILA5.02 Trillion ILA).
- JERONIMO MARTINS UN.ADR/2 (F:JEM0): Ranked #1764 globally with a market cap of $13.46 Billion USD ( €11.51 Billion EUR).
- Juniper Networks Inc (NYSE:JNPR): Ranked #1773 globally with a market cap of $13.36 Billion USD.
- Nextracker Inc. Class A Common Stock (NASDAQ:NXT): Ranked #1774 globally with a market cap of $13.34 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1763 | Azrieli Group Ltd | TA:AZRG | $13.46 Billion | ILA40340.00 |
| #1764 | JERONIMO MARTINS UN.ADR/2 | F:JEM0 | $13.46 Billion | €40.60 |
| #1773 | Juniper Networks Inc | NYSE:JNPR | $13.36 Billion | $39.95 |
| #1774 | Nextracker Inc. Class A Common Stock | NASDAQ:NXT | $13.34 Billion | $89.87 |
Argen-X Historical Marketcap From 2015 to 2026
Between 2015 and today, Argen-X's market cap moved from $352.83 Million to $ 28.38 Billion, with a yearly change of 50.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €28.38 Billion | +4.57% |
| 2025 | €27.14 Billion | +19.52% |
| 2024 | €22.71 Billion | +73.30% |
| 2023 | €13.10 Billion | -1.65% |
| 2022 | €13.32 Billion | +11.37% |
| 2021 | €11.96 Billion | +30.62% |
| 2020 | €9.16 Billion | +67.52% |
| 2019 | €5.47 Billion | +69.33% |
| 2018 | €3.23 Billion | +73.60% |
| 2017 | €1.86 Billion | +268.57% |
| 2016 | €504.58 Million | +43.01% |
| 2015 | €352.83 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Argen-X was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.37 Billion USD |
| MoneyControl | $13.37 Billion USD |
| MarketWatch | $13.37 Billion USD |
| marketcap.company | $13.37 Billion USD |
| Reuters | $13.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Argen-X
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgarti… Read more